Abstract:Chemical probes of epigenetic 'readers' of histone post-translational modifications (PTMs) have become powerful tools for mechanistic and functional studies of their target proteins in physiology and pathology. However, only limited 'reader' probes have been developed, which restricted our understanding towards these macromolecules and their roles in cells or animals. Here, we reported a structure-guided approach to develop and characterize benzo [d]oxazol-2(3H)-one analogs as the first potent and selective small-molecule inhibitors of chromodomain Y-like (CDYL), a histone methyllysine reader protein. The binding conformation between the chromodomain of CDYL and the modified peptidomimetics was studied via molecular docking and dynamic simulations, facilitating subsequent virtual screening of tens of hits from Specs chemical library validated by SPR technique (KD values: from 271.1 μM to 5.4 μM). Further design and synthesis of 43 compounds helped to interpret the structure-activity relationship (SAR) that lead to the discovery of novel small-molecule inhibitors of CDYL. Compound D03 (KD: 0.5 μM) was discovered and showed excellent selectivity among other chromodomain proteins, including CDYL2 (>140 folds), CDY1 (no observed binding) and CBX7 (>32 folds). Moreover, we demonstrated that D03 engaged with endogenous CDYL in a dose-dependent manner, and perturbed the recruitment of CDYL onto chromatin, resulting in transcriptional derepression of its target genes. Finally, the results showed that D03 promoted the development and branching of neurodendrites by inhibiting CDYL in hippocampal and cortical cultured neurons. This study not only discovers the first selective small-molecule inhibitors of CDYL, but provids a new chemical tool to intervene the dynamic nature of bio-macromolecules involved in epigenetic mechanism.

Crystal structure of Tudor domain of TDRD3 in complex with a small molecule antagonist

Structural Plasticity of the TDRD3 Tudor Domain Probed by a Fragment Screening Hit

Crystal Structure of TDRD3 and Methyl-Arginine Binding Characterization of TDRD3, SMN and SPF30.

Danthron Functions as a Retinoic X Receptor Antagonist by Stabilizing Tetramers of the Receptor

Structural Basis for Retinoic X Receptor Repression on the Tetramer

Structure-Guided Discovery Of A Potent And Selective Cell-Active Inhibitor Of Setdb1 Tudor Domain

Discovery of Novel Disruptor of Silencing Telomeric 1-Like (DOT1L) Inhibitors Using a Target-Specific Scoring Function for the (S)-Adenosyl-l-methionine (Sam)-Dependent Methyltransferase Family.

Structural View on the Role of the TRD Loop in Regulating DNMT3A Activity: a Molecular Dynamics Study.

Synthesis and Molecular Recognition Studies on Small-Molecule Inhibitors for Thioredoxin Reductase

Structural view on the role of TRD loop in regulating DNMT3A activity: a molecular dynamics study

Structural Studies of WDR5 in Complex with MBD3C WIN Motif Reveal a Unique Binding Mode

Molecular Modeling and Molecular Dynamics Simulation Studies on Pyrrolopyrimidine-Based Α-Helix Mimetic As Dual Inhibitors of MDM2 and MDMX

A Small Molecule Antagonist of SMN Disrupts the Interaction Between SMN and RNAP II

Identification and Characterization of Benzo[d]oxazol-2(3H)-one Derivatives As the First Potent and Selective Small-Molecule Inhibitors of Chromodomain Protein CDYL

Identification of a novel small-molecule inhibitor targeting TIM-3 for cancer immunotherapy

NMR Fragment-Based Screening Against Tandem RNA Recognition Motifs of TDP-43.

3D-QSAR and Docking Studies on 2-Arylbenzoxazole and Linker-Y Transthyretin Amyloidogenesis Inhibitors

Crystal Structure Of The Catalytic Domain Of A Human Thioredoxin-Like Protein - Implications For Substrate Specificity And A Novel Regulation Mechanism

Design, Synthesis, and Bioevaluation of Transcriptional Enhanced Assocciated Domain (TEAD) PROTAC Degraders

Identification of Novel Disruptor of Telomeric Silencing 1-like (DOT1L) Inhibitors through Structure-Based Virtual Screening and Biological Assays.

Conformational Selection in Ligand Recognition by the First Tudor Domain of PHF20L1